The FDA has approved a drug called Aduhelm to treat Alzheimer’s disease. This is a new type of Alzheimer’s treatment that addresses the disease in a way that has never been done before. Dr. Jonathan Liss, a Neurologist specializing on cognitive health who had a role in the trials of the new drug, Linda Davidson, Executive Director of the Alzheimer’s Association Georgia Chapter, and Robert Reid Denise Arrabas who are caregivers.